Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Integrin-Targeted Surface Enhanced Raman Gold Nanoparticles for in vivo Lung Cancer Imaging

EF 2011-12

Résumé
Cancer is the leading cause of death worldwide, with lung cancer accounting for 1.4 million deaths in 2008, reported by the WHO. Consequently, detection of cancer at its early stages has been identified as a potent way to reduce cancer mortality rate. While cancer diagnosis has been greatly improved in the recent past, current diagnosis often have the associated risks due to the use of ionizing radiation and the highly invasive nature of biopsies. Conversely, a new method for cancer detection is to use molecular reporters on gold nanoparticles to help doctors indisputably carryout a diagnosis. Gold is a non-toxic, biocompatible substance inside the body. Interestingly, by tuning the size of these particles to the nano-regime some of their exotic optical properties can be utilized to significantly intensify the signal of nearby molecular reporters. Small targeting molecules that have been proven to specifically bind to lung cancer cells will be added to the surface of these nanoparticles to help the particles distinguish cancerous from normal tissue. This technique shall use the unique ability of targeted molecules on gold nanoparticles to specifically and with high sensitivity to target tumours. Due to the high signal intensity of these nanoparticles, a clinician will be able to administer them inside the body and image the patient's tumour outside of the body with an optical detection device in a non-invasive manner. Additionally, since non-ionizing radiation (viz. x-rays) are not being used, a larger population can in theory be regularly screened for lung cancer without the down-the-road risks associated with radiation. Thus, the research herein proposed aims to develop a non-invasive, non-ionizing optical imaging modality to improve detection of early lung tumours with minimal risks to patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
255029
Name
Farhadi Arash
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Integrin-Targeted Surface Enhanced Raman Gold Nanoparticles for in vivo Lung Cancer Imaging
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Confocal Microscopy; Contrast Agent; Fluorescence Spectroscopy; Gold Nanoparticles; Lipid Encapsulation; Lung Cancer; Raman Spectroscopy; Surface Enhanced Raman Scattering; Targeted Nanoparticles; Tissue Culture
Abstract
Cancer is the leading cause of death worldwide, with lung cancer accounting for 1.4 million deaths in 2008, reported by the WHO. Consequently, detection of cancer at its early stages has been identified as a potent way to reduce cancer mortality rate. While cancer diagnosis has been greatly improved in the recent past, current diagnosis often have the associated risks due to the use of ionizing radiation and the highly invasive nature of biopsies. Conversely, a new method for cancer detection is to use molecular reporters on gold nanoparticles to help doctors indisputably carryout a diagnosis. Gold is a non-toxic, biocompatible substance inside the body. Interestingly, by tuning the size of these particles to the nano-regime some of their exotic optical properties can be utilized to significantly intensify the signal of nearby molecular reporters. Small targeting molecules that have been proven to specifically bind to lung cancer cells will be added to the surface of these nanoparticles to help the particles distinguish cancerous from normal tissue. This technique shall use the unique ability of targeted molecules on gold nanoparticles to specifically and with high sensitivity to target tumours. Due to the high signal intensity of these nanoparticles, a clinician will be able to administer them inside the body and image the patient's tumour outside of the body with an optical detection device in a non-invasive manner. Additionally, since non-ionizing radiation (viz. x-rays) are not being used, a larger population can in theory be regularly screened for lung cancer without the down-the-road risks associated with radiation. Thus, the research herein proposed aims to develop a non-invasive, non-ionizing optical imaging modality to improve detection of early lung tumours with minimal risks to patients.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Farhadi, Arash
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~